Scholar Rock Insider Trades
NASDAQ: SRRKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 32 · $9.19M
- Shares bought / sold
- 0 / 193.47K
- Net activity
- Net selling $9.2 million
Scholar Rock insider activity
Over the last 12 months, Scholar Rock insiders reported 59 transactions on SEC Form 4: 0 open-market purchases and 32 sales. Insiders bought $0 and sold $9.2 million worth of stock, for net insider selling of $9.2 million. The largest seller was Qatanani Mo, with $2.4 million in reported sales.
The most recent filing shows Woods Keith (Chief Operating Officer) reporting a transaction in 48,034 shares on Sep 24, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SRRK's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SRRK insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 24, 2026 | Woods KeithChief Operating Officer | Gift | 48,034 | — | Form 4 |
| Sep 21, 2026 | Hallal DavidChief Executive Officer | Gift | 36,652 | — | Form 4 |
| Jul 1, 2026 | Peng KatieDirector | Sale | 21 | $1.15K | Form 4 |
| Jul 1, 2026 | Peng KatieDirector | Sale | 2,437 | $132.21K | Form 4 |
| Jul 1, 2026 | Peng KatieDirector | Sale | 2,988 | $160.04K | Form 4 |
| Jul 1, 2026 | Reed JoshuaDirector | Sale | 948 | $51.46K | Form 4 |
| Jul 1, 2026 | Reed JoshuaDirector | Sale | 2,105 | $112.61K | Form 4 |
| Jul 1, 2026 | Burow KristinaDirector | Sale | 948 | $51.46K | Form 4 |
| Jul 1, 2026 | Burow KristinaDirector | Sale | 2,105 | $112.60K | Form 4 |
| Jul 1, 2026 | FLIER JEFFREY S.Director | Sale | 15 | $823.14 | Form 4 |
| Jul 1, 2026 | FLIER JEFFREY S.Director | Sale | 1,470 | $79.73K | Form 4 |
| Jul 1, 2026 | FLIER JEFFREY S.Director | Sale | 1,568 | $83.94K | Form 4 |
| Jul 1, 2026 | Gilman MichaelDirector | Sale | 43 | $2.36K | Form 4 |
| Jul 1, 2026 | Gilman MichaelDirector | Sale | 1,155 | $62.63K | Form 4 |
| Jul 1, 2026 | Gilman MichaelDirector | Sale | 1,346 | $72.07K | Form 4 |
| Jun 4, 2026 | AKKARAJU SRINIVASDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | Peng KatieDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | Gilman MichaelDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | Reed JoshuaDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | Burow KristinaDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | Brudnick RichardDirector | Award | 6,839 | — | Form 4 |
| Jun 4, 2026 | FLIER JEFFREY S.Director | Award | 6,839 | — | Form 4 |
| Apr 23, 2026 | Burow KristinaDirector | Option exercise | 18,000 | $150.48K | Form 4 |
| Apr 23, 2026 | Burow KristinaDirector | Option exercise | 36,000 | $327.96K | Form 4 |
| Apr 23, 2026 | Burow KristinaDirector | Option exercise | 28,000 | $133.00K | Form 4 |
| Apr 23, 2026 | Burow KristinaDirector | Option exercise | 7,800 | $208.88K | Form 4 |
| Apr 16, 2026 | Hallal DavidChief Executive Officer | Sale | 30,615 | $1.52M | Form 4 |
| Apr 16, 2026 | Sinha VikasChief Financial Officer | Sale | 10,410 | $516.07K | Form 4 |
| Apr 16, 2026 | Woods KeithChief Operating Officer | Sale | 10,220 | $506.65K | Form 4 |
| Apr 16, 2026 | Vaishnaw AkshayPresident of R&D | Sale | 12,246 | $607.09K | Form 4 |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 200 | $9.70K | Form 4 |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 857 | $41.01K | Form 4 |
| Feb 23, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 7,427 | $348.64K | Form 4 |
| Feb 17, 2026 | Parlavecchio CarynCHRO | Sale | 9,035 | $420.38K | Form 4 |
| Feb 17, 2026 | Ho JunlinGENERAL COUNSEL | Sale | 9,580 | $445.74K | Form 4 |
| Feb 17, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | 4,157 | $193.42K | Form 4 |
| Feb 17, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 7,989 | $371.71K | Form 4 |
| Feb 9, 2026 | Parlavecchio CarynChief Human Resources Officer | Award | 29,258 | — | Form 4 |
| Feb 9, 2026 | Hallal DavidChief Executive Officer | Award | 128,004 | — | Form 4 |
| Feb 9, 2026 | Woods KeithChief Operating Officer | Award | 47,021 | — | Form 4 |
| Feb 9, 2026 | Qatanani MoChief Scientific Officer | Award | 29,258 | — | Form 4 |
| Feb 9, 2026 | Sinha VikasChief Financial Officer | Award | 47,021 | — | Form 4 |
| Feb 9, 2026 | Ho JunlinGeneral Counsel | Award | 36,572 | — | Form 4 |
| Feb 9, 2026 | Marantz Jing L.Chief Medical Officer | Award | 34,482 | — | Form 4 |
| Feb 9, 2026 | Vaishnaw AkshayPresident of R&D | Award | 47,021 | — | Form 4 |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 12,779 | $598.75K | Form 4 |
| Jan 22, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 2,119 | $97.19K | Form 4 |
| Jan 16, 2026 | Ho JunlinGENERAL COUNSEL | Sale | 8,016 | $356.53K | Form 4 |
| Jan 16, 2026 | Parlavecchio CarynCHRO | Sale | 6,600 | $293.55K | Form 4 |
| Jan 16, 2026 | Marantz Jing L.CHIEF MEDICAL OFFICER | Sale | 5,798 | $257.88K | Form 4 |
| Jan 16, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 8,406 | $373.88K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Sale | 13,112 | $592.61K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise | 2,678 | $94.13K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise | 5,893 | $92.81K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise | 2,813 | $28.13K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise | 321 | $2.45K | Form 4 |
| Jan 14, 2026 | Qatanani MoCHIEF SCIENTIFIC OFFICER | Option exercise | 1,407 | $25.44K | Form 4 |
| Jan 13, 2026 | Sinha VikasChief Financial Officer | Sale | 16,755 | $715.44K | Form 4 |
| Dec 11, 2025 | Invus Global Management, LLC & Siren, L.L.C. & DEBBANE RAYMOND10% Owner | Option exercise | 1,575,008 | $11.58M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4